Live Biotherapeutic Products And Microbiome CDMO Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (C. Difficile, Crohn’s Disease, IBS, Diabetes), By Region (North America, Europe, APAC, MEA), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Regional Scope
                        1.1.2. Estimates and Forecast Timeline
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Purchased Database
                        1.3.3. GVR’s Internal Database
                        1.3.4. Secondary Sources
                        1.3.5. Primary Research
                    1.4. Information or Data Analysis
                        1.4.1. Information Analysis
                        1.4.2. Market Formulation & Data Visualization
                        1.4.3. Data Validation & Publishing
                    1.5. Model Details
                        1.5.1. Commodity Flow Analysis (Model 1)
                        1.5.2. Top Down Market Estimation (Model 2)
                        1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
                        1.5.4. Multivariate Analysis (Model 4)
                    1.6. List of Secondary Sources
                    1.7. List of Abbreviations
                    1.8. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. Live Biotherapeutic Products And Microbiome CDMO Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. High Potential of Live Biotherapeutic Products and Microbiome in Treating Chronic & Infectious Diseases
                            3.2.1.2. Increase in Clinical Research on Live Biotherapeutic Products
                            3.2.1.3. Increasing Demand for One-Stop-Shop CDMOs
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Compliance Issues in Outsourcing
                            3.2.2.2. Availability of Substitutes
                    3.3. Technology Landscape
                    3.4. Pricing Model Analysis
                    3.5. Clinical Trial Volume Analysis, 2024
                    3.6. Industry Market Analysis Tools
                        3.6.1. Porter’s Five Forces Analysis
                        3.6.2. PESTEL Analysis
                        3.6.3. COVID-19 Impact Analysis
Chapter 4. Live Biotherapeutic Products and Microbiome CDMO Market: Application Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Global Live Biotherapeutic Products and Microbiome CDMO Market Application Movement Analysis
                    4.3. Global Live Biotherapeutic Products and Microbiome CDMO Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    4.4. C. Difficle
                        4.4.1. C. Difficle Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Crohn’s disease
                        4.5.1. Crohn's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. IBS
                        4.6.1. IBS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Diabetes
                        4.7.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. Others
                        4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pharmaceutical Transportation Services Market: Regional Estimates & Trend Analysis
                    5.1. Regional Market Share Analysis, 2024 & 2030
                    5.2. Regional Market Dashboard
                    5.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
                    5.4. North America
                        5.4.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        5.4.2. U.S.
                            5.4.2.1. Key country dynamics
                            5.4.2.2. Competitive scenario
                            5.4.2.3. Regulatory scenario
                            5.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Canada
                            5.4.3.1. Key country dynamics
                            5.4.3.2. Competitive scenario
                            5.4.3.3. Regulatory scenario
                            5.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Mexico
                            5.4.4.1. Key country dynamics
                            5.4.4.2. Competitive scenario
                            5.4.4.3. Regulatory scenario
                            5.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.5. Europe
                        5.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        5.5.2. UK
                            5.5.2.1. Key country dynamics
                            5.5.2.2. Competitive scenario
                            5.5.2.3. Regulatory scenario
                            5.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Germany
                            5.5.3.1. Key country dynamics
                            5.5.3.2. Competitive scenario
                            5.5.3.3. Regulatory scenario
                            5.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.4. France
                            5.5.4.1. Key country dynamics
                            5.5.4.2. Competitive scenario
                            5.5.4.3. Regulatory scenario
                            5.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.5. Italy
                            5.5.5.1. Key country dynamics
                            5.5.5.2. Competitive scenario
                            5.5.5.3. Regulatory scenario
                            5.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.6. Spain
                            5.5.6.1. Key country dynamics
                            5.5.6.2. Competitive scenario
                            5.5.6.3. Regulatory scenario
                            5.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.7. Denmark
                            5.5.7.1. Key country dynamics
                            5.5.7.2. Competitive scenario
                            5.5.7.3. Regulatory scenario
                            5.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.8. Norway
                            5.5.8.1. Key country dynamics
                            5.5.8.2. Competitive scenario
                            5.5.8.3. Regulatory scenario
                            5.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.9. Sweden
                            5.5.9.1. Key country dynamics
                            5.5.9.2. Competitive scenario
                            5.5.9.3. Regulatory scenario
                            5.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.6. Asia Pacific
                        5.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        5.6.2. Japan
                            5.6.2.1. Key country dynamics
                            5.6.2.2. Competitive scenario
                            5.6.2.3. Regulatory scenario
                            5.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.6.3. China
                            5.6.3.1. Key country dynamics
                            5.6.3.2. Competitive scenario
                            5.6.3.3. Regulatory scenario
                            5.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.6.4. India
                            5.6.4.1. Key country dynamics
                            5.6.4.2. Competitive scenario
                            5.6.4.3. Regulatory scenario
                            5.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.6.5. Australia
                            5.6.5.1. Key country dynamics
                            5.6.5.2. Competitive scenario
                            5.6.5.3. Regulatory scenario
                            5.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.6.6. South Korea
                            5.6.6.1. Key country dynamics
                            5.6.6.2. Competitive scenario
                            5.6.6.3. Regulatory scenario
                            5.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.6.7. Thailand
                            5.6.7.1. Key country dynamics
                            5.6.7.2. Competitive scenario
                            5.6.7.3. Regulatory scenario
                            5.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.7. Latin America
                        5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        5.7.2. Brazil
                            5.7.2.1. Key country dynamics
                            5.7.2.2. Competitive scenario
                            5.7.2.3. Regulatory scenario
                            5.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.7.3. Argentina
                            5.7.3.1. Key country dynamics
                            5.7.3.2. Competitive scenario
                            5.7.3.3. Regulatory scenario
                            5.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.8. MEA
                        5.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        5.8.2. South Africa
                            5.8.2.1. Key country dynamics
                            5.8.2.2. Competitive scenario
                            5.8.2.3. Regulatory scenario
                            5.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.8.3. Saudi Arabia
                            5.8.3.1. Key country dynamics
                            5.8.3.2. Competitive scenario
                            5.8.3.3. Regulatory scenario
                            5.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.8.4. UAE
                            5.8.4.1. Key country dynamics
                            5.8.4.2. Competitive scenario
                            5.8.4.3. Regulatory scenario
                            5.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.8.5. Kuwait
                            5.8.5.1. Key country dynamics
                            5.8.5.2. Competitive scenario
                            5.8.5.3. Regulatory scenario
                            5.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Competition Categorization
                    6.2. Company Market Assessment Analysis, 2024
                    6.3. Company Profiles
                        6.3.1. Arrant Bio
                            6.3.1.1. Company overview
                            6.3.1.2. Financial performance
                            6.3.1.3. Service benchmarking
                            6.3.1.4. Strategic initiatives
                        6.3.2. 4D Pharma
                            6.3.2.1. Company overview
                            6.3.2.2. Financial performance
                            6.3.2.3. Service benchmarking
                            6.3.2.4. Strategic initiatives
                        6.3.3. Cerbios
                            6.3.3.1. Company overview
                            6.3.3.2. Financial performance
                            6.3.3.3. Service benchmarking
                            6.3.3.4. Strategic initiatives
                        6.3.4. Biose Industrie
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Service benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Assembly Biosciences, Inc.
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Service benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Wacker Chemie AG
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Service benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. Quay Pharmaceuticals
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Service benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. NIZO
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Service benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. Lonza
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Service benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. Inpac Probiotics
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Service benchmarking
                            6.3.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global live biotherapeutic products and microbiome CDMO market, by Region, 2018 - 2030 (USD Million)
Table 4 Global live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 5 North America live biotherapeutic products and microbiome CDMO market, by country, 2018 - 2030 (USD Million)
Table 6 North America live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 8 Canada live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 9 Mexico live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 10 Europe live biotherapeutic products and microbiome CDMO market, by country, 2018 - 2030 (USD Million)
Table 11 Europe live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 12 UK live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 13 Germany live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 14 France live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 15 Italy live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 16 Spain live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 17 Denmark live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 18 Sweden live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 19 Norway live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 20 Asia Pacific live biotherapeutic products and microbiome CDMO market, by country, 2018 - 2030 (USD Million)
Table 21 Asia Pacific live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 22 Japan live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 23 China live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 24 India live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 25 Australia live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 26 South Korea live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 27 Thailand live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 28 Latin America live biotherapeutic products and microbiome CDMO market, by country, 2018 - 2030 (USD Million)
Table 29 Latin America live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 30 Brazil live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 31 Argentina live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 32 MEA live biotherapeutic products and microbiome CDMO market, by country, 2018 - 2030 (USD Million)
Table 33 MEA live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 34 South Africa live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 36 UAE live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)
Table 37 Kuwait live biotherapeutic products and microbiome CDMO market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Live biotherapeutic products and microbiome CDMO market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Commodity flow analysis
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Parent market outlook, 2024 (USD Billion)
Fig. 12 Ancillary market outlook, 2024 (USD Billion)
Fig. 13 Live biotherapeutic products and microbiome CDMO market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 Live biotherapeutic products and microbiome CDMO market: PESTEL analysis
Fig. 16 Live biotherapeutic products and microbiome CDMO market, by application, 2024 (USD Million)
Fig. 17 Companies with affected trials, by size
Fig. 18 Affected trials, by study phase
Fig. 19 Clinical trial scenario (as of January 2024)
Fig. 20 Live biotherapeutic products and microbiome CDMO market: Application outlook and key takeaways
Fig. 21 Live biotherapeutic products and microbiome CDMO market: Application movement analysis
Fig. 22 C. difficile market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Crohn's disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 IBS market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Regional market: Key takeaways
Fig. 28 Regional outlook, 2024 & 2030
Fig. 29 Regional outlook, key takeaways
Fig. 30 North America live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Key country dynamics
Fig. 32 U.S. live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Canada live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Europe live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 UK live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Germany live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 France live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Italy live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Spain live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Denmark live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Sweden live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Norway live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 China live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Japan live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 India live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Australia live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Thailand live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 South Korea live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Latin America live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Brazil live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Mexico live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Argentina live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 MEA live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 South Africa live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UAE live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Kuwait live biotherapeutic products and microbiome CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Market participant categorization
Fig. 82 Heat map analysis
Fig. 83 Market participant categorization